• Leading brokers name 3 ASX shares to sell today

    laptop keyboard with red sell button

    On Monday I looked at three ASX shares that brokers have given buy ratings to this week.

    Unfortunately, not all shares are in favour with them right now. Three that have just been given sell ratings are listed below.

    Here’s why these brokers are bearish on these ASX shares:

    Mineral Resources Limited (ASX: MIN)

    According to a note out of Morgan Stanley, its analysts have retained their underweight rating but lifted their price target on this mining and mining services company’s shares slightly to $23.50. This follows the release of a quarterly update that fell short of the broker’s expectations. In light of this and its valuation, which it has previously noted looks stretched, it holds firm with its bearish rating. The Mineral Resources share price is trading at $25.46 this afternoon.

    National Australia Bank Ltd (ASX: NAB)

    A note out of the Macquarie equities desk reveals that its analysts have retained their underperform rating and $17.50 price target on this banking giant’s shares. This follows the release of an update on a number of notable items that will impact its full year results. Outside this, it notes that it has exposure to the small to medium sized business market, which it feels is a risky area in the current environment. In light of this, it suspects its shares could underperform over the next 12 months. The NAB share price is fetching $19.02 on Tuesday.

    Premier Investments Limited (ASX: PMV)

    Analysts at Goldman Sachs have downgraded this retailer’s shares to a sell rating but lifted their price target on them to $19.20. According to the note, the broker points out that Premier Investments is trading on significantly higher multiples than any time over the last decade. It is also at the high end in comparison to global apparel peers. It also has concerns over the sustainability of the current low expense profile and the economic recovery impact on the apparel category. The Premier Investments share price is changing hands for $21.76 today.

    Man who said buy Kogan shares at $3.63 says buy these 3 ASX stocks now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Premier Investments Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Leading brokers name 3 ASX shares to sell today appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/37L67CH

  • Why these 7 ASX 200 shares received broker upgrades this week

    hand selecting happy face from choice of happy, sad and neutral signifying best ASX shares

    A number of S&P/ASX 200 Index (ASX: XJO) shares in the travel, materials, construction and healthcare sectors have received broker upgrades this week. This follows strong quarterly results and a general anticipated recovery within their respective sectors.

    Austal Limited (ASX: ASB) 

    Goldman Sachs retained its buy rating on Austal with a price target of $4.35 in anticipation that its annual general meeting commentary will reflect a strong earnings outlook. 

    Beach Energy Ltd (ASX: BPT) 

    Citi raised its Beach Energy share price target from $1.91 to $1.98 and retains a buy rating. The company’s quarterly production update was solid but slightly missed expectations. It anticipates upside from Beach Energy’s upcoming drilling results. 

    Bluescope Steel Limited (ASX: BSL) 

    A series of upgrades came in for the Bluescope Steel share price including: 

    • Citi raises price target from $14.00 to $16.00 
    • Credit Suisse raises price target from $15.55 to $16.95 
    • Macquarie raises price target from $16.20 to $19.05 
    • Morgan Stanley raises price target from $11.00 to $16.00 
    • UBS raises price target from $13.10 to $15.70 

    This was on the back of the company’s strong first half results and anticipated benefit from fiscal stimulus measures in Australia and the US. 

    CSR Limited (ASX: CSR)

    Sticking to the theme of materials and construction, Credit Suisse upgraded the CSR share price target from $4.10 to $5.30. It expects fiscal stimulus measures to underpin earnings in the short-medium term. 

    National Australia Bank Ltd (ASX: NAB)

    The NAB share price received mixed broker opinions. Credit Suisse retained an outperform rating with a $21.30 price target and UBS retained a buy rating with a $20.50 price target. The brokers believe that the company is on top of the current situation and should continue to navigate sensibly through the crisis. 

    Conversely, Macquarie retained an underperform rating with a $17.50 price target. While it considers the valuation attractive, it has concerns about earnings risks in the short-medium term. 

    Qantas Airways Limited (ASX: QAN)

    Morgan Stanley reiterated its overweight rating and retains its Qantas share price target of $4.90. It predicts that domestic capacity will improve to approximately 50% by Christmas but is highly dependent on state border re-openings. 

    Resmed CDI (ASX: RMD) 

    Morgan Stanley raised its Resmed share price target from $25.40 to $25.90. It believes that the company will continue to deliver strong growth despite the pandemic. 

    Man who said buy Kogan shares at $3.63 says buy these 3 ASX stocks now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    Lina Lim has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Austal Limited. The Motley Fool Australia has recommended ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Why these 7 ASX 200 shares received broker upgrades this week appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/37WSlgL

  • Why is the Bravura (ASX:BVS) share price dropping today?

    mesoblast share price falling represented by cartoon of little business men falling off broken graph arrow

    The Bravura Solutions Ltd (ASX: BVS) share price has dropped today following the announcement of a new contract win.

    During market open, the news sent the software solutions company shares to an intra-day high of $3.31. However, negative market sentiment has caused a retreat in the Bravura share price, which has now fallen 4.24% to $3.16 at the time of writing.

    Contract win

    According to the release, Bravura signed a long-term contract with Aware Super for a suite of software products. The agreement will allow Aware Super to use Bravura’s ecosystem to support the administration of retirement savings.

    Aware Super is the second largest superannuation funds in Australia, managing close to $130 billion in retirement savings. The company has over 1 million members and supports them with superannuation, retirement, investments and advice.

    What’s in the deal

    Bravura will provide its Sonata Alta operating model that encompasses AdviceOS, Babel SuperStream messaging and member, and adviser digital products. The deal will assist in Aware Super’s running of superannuation, income stream, unit trust and advice offerings.

    Sonata Alta is a new, digital platform that automates administration tasks through its cloud business-process-automation-as-a-service (BPaaS). The product gives complete visibility of super fund performance and insights to create a personalised experience for customers.

    A dedicated support team will also be on standby for any service-related enquiries.

    Both parties have signed the contract for an initial term of 7 years.

    What did both companies say?

    Bravura CEO, Mr Tony Klim commented on the new deal:

    We are delighted to provide Bravura’s world-class technology to Aware Super. Sonata Alta and Bravura’s ecosystem of products are ideally suited to providing Aware Super unprecedented control, flexibility and a highly personalised member experience at scale to support their members for and in retirement.

    Ms Deanne Stewart, Aware CEO, added:

    After a rigorous selection process, Aware Super selected Bravura as its technology partner for this key initiative. We look forward to working closely with Bravura to deliver exceptional outcomes for our members.

    Outlook

    Bravura advised that due to the impact of COVID-19 on businesses, there has been greater uncertainty in the timing of deal closures.

    Despite the new contract win with Aware Super, Bravura noted that its FY21 outlook remains unchanged. Because of the second wave lockdowns in the UK and stalling Brexit negotiations, its pipeline opportunities are being slowed.

    The company expects its net profit after tax for FY21 to be significantly weighted to the second-half of the financial year.

    About the Bravura share price

    The Bravura share price has been trending lower since May, falling over 30% and its shares are currently trading back near their March lows.

    The company has a market capitalisation of $781 million and a P/E ratio of 19.46.

    Man who said buy Kogan shares at $3.63 says buy these 3 ASX stocks now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Bravura Solutions Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Why is the Bravura (ASX:BVS) share price dropping today? appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/34wAXNG

  • Vmoto (ASX:VMT) share price flat despite record sales

    electric scooter zooming along signifying surging share price

    Australian electric scooter maker Vmoto Ltd (ASX: VMT) announced a market update on its activities for the third quarter ending 30 September.

    The company reported record growth in sales of 7,009 units during the quarter, and record international sales year to date of 15,847 units.  This is 35% higher than the corresponding period in 2019, and 107% up on the same period in 2018.

    The Vmoto share price is trading flat at 51.5 cents at the time of writing. 

    Who does Vmoto do?

    Vmoto is a Perth-based company that manufactures and distributes electric-powered two-wheel vehicles. Its factory is located in Nanjing, China.

    The company has marketed itself as a premium maker of electric scooters with chic European design, coupled with German engineering. Vmoto is also involved in the manufacture of petrol-based scooters, however this represents a small part of its product line-up.

    Highlights from today’s market update 

    In 2020, Vmoto has undergone a strategic review on its operations to focus on the international sales of its high margin electric two-wheel product segment. Although 91% of sales are in China, the company wants to give more focus on the European market. 

    The highlights of the announcement today include:

    • International sales in 3Q20 beat its biggest competitor Niu Technologies (NASDAQ: NIU) – 7,009 units for Vmoto vs 5,596 units for Niu Technologies. This validates Vmoto’s competitiveness in international markets.
    • A net cash position of AU$ 15.3 million. This is net of debt.
    • There are significant inquiries from the business-to-business (B2B) segment especially from food delivery and ride-sharing companies. Advanced discussions are under way to secure those contracts.
    • A European government’s initiative to subsidise the purchase of electric two-wheel vehicles will have longer term positive impact for the company.
    • The company has secured international orders for 6,512 units to be delivered post 3Q20.
    • The company has consistently delivered increasing sales every year since 2018.

    The share price of Vmoto has increased by 117% this year at today’s trading. It has a market cap of AU$148.5 million at today’s value. 

    The current state of electric motorcycles

    The COVID-19 pandemic has accelerated the purchase of two-wheeled vehicles around the world – both by individuals as well as companies such as food delivery. In the city of London for example, new motorcycle registrations in 2020 were up by 31% compared to the same period last year. Food delivery company Deliveroo has seen its riders doubled in the UK within a year, with similar numbers across Europe. 

    However, the electrical segment still only represents a small percentage of the motorcycle market.  In India, which is the world’s largest motorcycle market, it’s still less than 1%. 

    The key to mass adoption of electric motorcycles will be the provision and ubiquity of Electric Vehicle (EV) charger stations in metropolitan areas. Some European governments  have begun discussions with private entities to install these EV stations around the major cities.

    Man who said buy Kogan shares at $3.63 says buy these 3 ASX stocks now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    Motley Fool contributor dsunarto has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Vmoto (ASX:VMT) share price flat despite record sales appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3ml9vbu

  • ASX stock of the day: Strategic Elements (ASX:SOR) surges 170% on new self-charging battery

    Man looking excitedly at computer screen against backdrop of streamers

    Today, our ASX stock of the day is Strategic Elements Ltd (ASX: SOR). The Strategic Elements share price is certainly having a top day today. It has surged more than 170% from 6.5 cents a share yesterday to 18 cents a share at the time of writing (a new 52-week high). That means a $1,000 investment yesterday would now worth approximately $2,077 today. Not bad.

    Today’s gains cap off what has been a volatile year in 2020 so far for this company. Strategic Elements shares have a 52-week range of 3 cents to today’s new high of 18 cents. But before today, the share price went nowhere over the past month, staying flat at 7 cents.

    But why such a massive change in valuation over the space of one day? Well, the company did make an announcement to the markets this morning that seems to be why its shares are reaching for the stars today. But more on that later.

    Who is Strategic Elements?

    Strategic Elements is a very interesting kind of company, and one you might not have run into before. The company tells us that it “operates as a venture builder where it generates ventures and projects from combining teams of leading scientists or innovators in the technology or resources sectors.”

    Importantly, the company describes itself as a “registered Pooled Developed Fund (PDF)”. According to Strategic Elements, a PDF means that “our investors pay no tax on capital gains or dividends to compensate for the higher risk of investing in small and medium-sized companies.”

    The federal government’s business.gov.au website confirms this arrangement. It states that the PDF program aims to “increase the supply of capital to Australian small and medium-sized enterprises (SMEs).”

    According to the government, under the arrangement:

    PDFs and their shareholders receive tax benefits on the income derived from their equity investments. This is to help compensate for the higher risk of investing in SMEs. PDFs will be taxed at 15% on the income and gains derived from equity investments in Australian SMEs. Shareholders are exempt from tax on the income and gains derived from holding and disposing of PDF shares.

    Strategic Elements aims to use this program to “take part in projects that explore brand new fields of innovation”. However, it also notes that, under the PDF arrangement, investments in retail or property investments are not permitted.

    At the moment, some of Strategic Elements’ investments include an artificial intelligence and robotics company called Stealth Technologies, as well as a meteorite mining company (Australian Exploration Projects) and a company dedicated to making ‘memory ink’ (Nanocubes).

    A new self-charging battery?

    But Strategic Elements comes before us today for a different reason. It’s 100%-plus share price movement this morning can be put down to one announcement made before market open: a company in Strategic Elements’ portfolio is developing a self-charging battery technology. Strategic Elements’ subsidiary Australian Advanced Materials is collaborating with both the CSIRO and the University of New South Wales to develop the battery. According to the release:

    The battery cells create electricity from humidity in the air or skin surface to self-charge themselves within minutes. No manual charging or wired power is required. They are created with a printable ink and are ideally suited for use in Internet of Things (IOT) devices.

    The company notes that, if successful, the new battery technology would have a number of benefits over the existing lithium-ion rechargeable battery technology in widespread use today. These include non-flammability, weight reduction, no need for ‘plug-in charging’ and reduced environmental impact.

    The batteries will be made using ‘battery ink’ from Strategic Elements’ Nanocubes, as well as graphene oxide, which is derived from graphite, a form of carbon.

    Why are investors so excited about these batteries?

    With the Strategic Elements share price rising by more than 170% just today, I think it’s fairly safe to say investors are excited about this technology’s prospects. But why? I think the answer lies with this technology’s potential applications. Strategic Elements is very keen to tout the application of these batteries to the Internet of Things.

    Part of the company’s release states:

    The global battery market for IOT is already significant with US$8.7 billion in 2019 and is projected to grow to US$15.9 billion by 2025. The growing need for thin and flexible batteries in IOT and medical devices, along with inherent advantages of micro batteries provides significant opportunities.

    Rechargeable batteries are already being used for new applications. Most famously perhaps is by Tesla Inc (NASDAQ: TSLA). If Strategic Elements is really onto a winner here, it would have virtually limitless applications – including in electric vehicles. Further, companies working in this area, like Tesla and Nio Inc (NYSE: NIO), have recently seen significant investor interest and share price appreciation. I’m sure some of this goodwill and sentiment is flowing into Strategic Elements today.

    This is an interesting one to watch going forward!

    Man who said buy Kogan shares at $3.63 says buy these 3 ASX stocks now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    Sebastian Bowen owns shares of Tesla. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and recommends Tesla. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post ASX stock of the day: Strategic Elements (ASX:SOR) surges 170% on new self-charging battery appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3os8SyN

  • Do Australian companies pay more tax than our neighbours?

    comparing asx shares and company tax represented by an apple and orange side by side

    Company tax is often a sensitive topic. 

    Foreign multinationals are accused of not paying enough, local companies complain they pay too much, and businesses clever enough to domicile in low-tax regions are accused of tax-dodging.

    Conversely, nations manipulate their corporate tax level according to their needs. Lower it to attract business activity, or raise it to fund social spending.

    The stereotype is that wealthy European nations will have a higher tax rate to pay for their more generous social spending. And poorer countries have lower corporate taxes to entice business. 

    Accounting software provider QuickBooks recently actually did the sums to work out whether any of this is true.

    Australia has the 9th highest company tax

    Australia’s 30% company tax rate saw it ranked as the equal 9th highest in the world. In the Asia-Pacific region, only Japan’s company tax rate was higher, at 30.62%.

    Oddly enough, the highest taxing “country” on QuickBooks’ league table is not a country at all — it is the United States territory of Puerto Rico, which slugs businesses a whopping 37.5%.

    The biggest trend was that the old stereotype of developed nations having higher corporate taxes and poorer countries having lower rates was shattered.

    European countries on average had a tax rate of 20.27%, while Africa averaged 28.45%.

    South America was the most frequently represented in the top 10, with Brazil and Venezuelan businesses paying 34% in tax.

    “It is unclear whether South America, as an emerging continent, is charging higher taxes in order to raise government revenue or to benefit from businesses that are looking to expand internationally and enter new markets,” said QuickBooks analyst, Lucy Desai.

    “South America is becoming a popular choice for businesses to enter, with strong trade links and an advantageous geographic location.”

    Looking at the richest countries, there is no magic formula for company taxes – some charge high and some charge low.

    “The top five richest countries in the world’s corporation tax are relatively varied, with Luxemburg standing at 27.08%, Norway at 22%, Iceland at 20%, Switzerland at 18% and Ireland at 12.5%,” said Desai. 

    “It would appear that some countries’ cultures factor into how much tax they pay. For example, Scandinavian countries are proud to pay higher taxes to contribute to social welfare.”

    Countries with the highest corporate taxes

    Nation/region Company tax rate (%)
    Puerto Rico 37.5
    Zambia 35
    Brazil 34
    Venezuela 34
    France 33.3
    Columbia 33
    Morocco 31
    Japan 30.62
    Australia + 7 others 30
    Source: QuickBooks, table created by author

    Countries with the lowest corporate taxes

    Nation/region Company tax rate (%)
    Barbados 5.5
    Hungary 9
    Qatar 10
    Bulgaria 10
    Cyprus 12.5
    Ireland 12.5
    Iraq 15
    Kuwait 15
    Maldives 15
    Georgia 15
    Lithuania 15
    Source: QuickBooks, table created by author

     

    These 3 stocks could be the next big movers in 2020

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    Motley Fool contributor Tony Yoo has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Do Australian companies pay more tax than our neighbours? appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/31La5aC

  • Here’s how Adore Beauty (ASX:ABY) and these new IPOs have fared since listing

    Initial Public Offering (IPO)

    The month of October has certainly been a very busy one for IPOs.

    A number of shares have completed their IPOs this month and hit the ASX boards. Some more successfully than others.

    Here’s a summary of recent IPOs and how they have fared since listing:

    Adore Beauty Group Limited (ASX: ABY)

    The Adore Beauty share price has had a difficult start to life on the ASX boards. This afternoon the online beauty retailer’s shares are trading at $5.88. This represents a 13% decline from its IPO price of $6.75. 

    Adore Beauty raised $269.5 million from its IPO, giving it a market capitalisation of $635.3 million. The company intends to use the proceeds of its IPO to support its growth strategy and future growth opportunities. This includes growing its brand awareness, strengthening its offering, and expanding into new markets and adjacent categories.

    Aussie Broadband Limited (ASX:ABB)

    The Aussie Broadband share price has been a very strong performer since completing its IPO. On Tuesday afternoon the internet provider’s shares are fetching $1.89. This is up a sizeable 89% from its IPO listing price of $1.00.

    Aussie Broadband listed on the Australian share market after raising approximately $40 million through a partially underwritten initial public offering. The funds raised are going to be used predominantly on the deployment of a dark fibre network.

    CleanSpace Holdings Limited (ASX: CSX)

    The CleanSpace share price has also been a strong performer since listing on the Australian share market. The shares of the designer, manufacturer, and seller of workplace respiratory protection equipment (RPE) for healthcare and industrial end markets are trading at $6.88 this afternoon. This is up an impressive 56% from its listing price of $4.41.

    CleanSpace’s IPO raised a total of $131.4 million. Though, only $20 million of this was primary capital. The remainder is for long term shareholders to realise some of their investments.

    MyDeal.com.au Limited (ASX: MYD)

    The MyDeal.com.au share price is trading at $1.32 this afternoon. While this is notably higher than its IPO price of $1.00, it is materially lower than its high. The online retail marketplace provider’s shares rocketed 120% higher on their first day on the ASX boards to $2.20.

    MyDeal raised $40 million from its IPO, which comprises $35 million for the company and $5 million for certain existing shareholders. It intends to use the proceeds to drive future growth. This includes growing its private label business, investing in its proprietary technology, and investing in advertising to grow its customer base and brand.

    Zebit Inc (ASX: ZBT)

    The Zebit share price has had a disastrous start to life on the ASX boards. This afternoon the US-based e-commerce company’s shares are changing hands for 97.5 cents. This is down 38% from its IPO price of $1.58.

    The California-based company raised A$35 million, which it plans to use to rapidly accelerate its growth in North America. Zebit markets itself as the Amazon for the under-served, with a built in buy now pay later platform that provides credit to those that cannot get it elsewhere.

    Man who said buy Kogan shares at $3.63 says buy these 3 ASX stocks now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Here’s how Adore Beauty (ASX:ABY) and these new IPOs have fared since listing appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/31KQNm0

  • Will COVID-19’s second wave crash share markets a second time?

    downward arrow illustrating global share market crash

    In the ongoing share market battle between the coronavirus and the next rounds of government stimulus, the virus took the upper hand yesterday. Major indexes the world over closed well into the red. And it’s pushing down share prices on the S&P/ASX 200 Index (ASX: XJO) again today.

    On the virus side, case numbers are exploding across much of Europe and the United States. In efforts to minimise the tragic loss of lives, European nations are reimposing strict lockdowns sure to drag on their economies. And many US hospitals are already at or near capacity.

    Of course, it’s not just the US and Europe.

    Australia looks like it may join New Zealand and a handful of other less populated nations in containing or even eliminating the pandemic. But COVID-19 continues to expand across most of the rest of the world. Brazil, Mexico, India and Iran, to name a few, are all at or near record levels of new infections.

    And yesterday news broke that the world’s most populous nation, China, reported its first new local infection since 14 October.

    The reported case numbers were relatively small — 20 tested people showed symptoms while 161 were asymptomatic. But the prospect of a second wave in China was likely the culprit which drove the ASX 200 from early morning gains to close at a loss, while also driving the Aussie dollar lower.

    Bring on the stimulus

    With these alarming statistics in mind, investors are rightfully worried about the short to mid-term earnings outlooks for their shareholdings, and hence their share prices.

    Let’s not forget that when the first wave of COVID crashed across the globe it sent the ASX 200 down 37% in less than 5 weeks, before hitting bottom on 23 March.

    It was the same the world over.

    The S&P 500 Index (INDEXSP: .INX) lost 34% during the panic selling. Germany’s DAX PERFORMANCE-INDEX (INDEXDB: DAX) tumbled 39%. Japan’s Nikkei 225 (INDEXNIKKEI: NI225) fell by 31%.

    I could go on. But you get the idea. No major share market index in the world escaped the bloodbath.

    And what was it that pulled share prices back up from those depths?

    Record fiscal and monetary stimulus unleashed by the world’s leading central banks and wealthiest nations.

    Only then did markets look past the immediate spectre of the economic fallout from lockdowns and social distancing to the longer-term outlook of what had been – and likely will be again – high quality, high performing shares.

    At the moment all eyes are on the United States to do the next round of heavy lifting.

    And for good reason.

    The much-delayed new round of fiscal stimulus promises to be huge, regardless of how the final stages of negotiations work out. The White House now supports a US$1.9 trillion (AU$2.7 trillion) spending package. The Democrats are holding out for US$2.4 trillion.

    Unfortunately, this half-a-trillion-dollar gap again saw House Speaker Nancy Pelosi and Treasury Secretary Steven Mnuchin walk away (or hang up their phones) without reaching an agreement yesterday.

    Here’s what the pros are saying

    With so much riding on the stimulus versus virus battle, here are some soundbites from the market experts.

    According to Keith Buchanan, portfolio manager for GLOBALT Investments in Atlanta (quoted by Bloomberg here and here):

    Fiscal stimulus seems to not be coming as quickly as we thought and the virus is coming quicker than we imagined. Putting those two together is somewhat of a reality check for the markets…

    The gains we made from an economic standpoint have been predicated on the feeling like we can start to deal with the virus and continue the economic recovery out of the bottom. It’s a scary moment from an economic standpoint to have all of those indicators that the virus is getting worse as stimulus seems to be slowing down very dramatically.

    And David Donabedian, chief investment officer of CIBC Private Wealth Management says:

    The overwhelming consensus in the market is that while the economic recovery to date is impressive, it still needs help. It’s not ready to stand on its own, and so some fiscal support is necessary and does not really seem to be forthcoming before year-end…

    You really can’t blame the stock market for pulling back at any point given how far it’s come. It’s like a blast from the past – there’s rising concerns about COVID-19 and its impact on the economy.

    Then there’s Ryan Detrick, chief market strategist for LPL Financial:

    The double whammy of a stalled stimulus bill and new highs in cases is a harsh reminder of the many worries that are still out there. Most of the recent economic data has been strong, but when you see parts of Europe going back to rolling shutdowns, it reminds us this fight is still far from over.

    But it’s not all doom and gloom for the short-term share market outlook.

    A pre-election share market rally?

    As a long-term investor, I believe you can look beyond most of this renewed angst. I’m confident that new stimulus measures will pass in the US and other developed nations. And, in time, the virus will be vanquished with effective vaccines and rapid testing.

    On a much shorter time scale, next Tuesday, 3 November, marks the US presidential election. And if history is any guide, US – and likely Aussie – shares could rally into that date.

    Miller Tabak strategist Matt Maley says the “odds are high” markets will rally through to 3 November.

    As Bloomberg reports, in a note Maley wrote on Saturday, he pointed out the S&P 500 has rallied every time in the week before the presidential election since 1992, except 2016. The average gains in those 6 instances were 3.8%.

    Maley noted:

    Although the stock market fell 1.9% over the seven days of trading in 2016, you have to go all the way back to 1988 to find another time when it didn’t rally over the last week and a half of the election campaign.

    Nothing is ever guaranteed in the markets… but our point is that history does tell us that the odds are high that the market will rally between now and Election Day.

    With the average share price of the top 200 ASX companies down 1.3% at time of writing, we hope to see the pre-election market rally trend play out again this year.

    Man who said buy Kogan shares at $3.63 says buy these 3 ASX stocks now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Will COVID-19’s second wave crash share markets a second time? appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2JbgZjd

  • Alcidion (ASX:ALC) share price storms higher on update

    increase in asx medical software share price represented by doctor making excited hands up gesture

    Today, the Alcidion Group Ltd (ASX: ALC) share price is storming higher as the company released a positive quarterly report to the market. Shares in the e-health provider are rising strongly despite the sharp sell off in the All Ordinaries Index (ASX: XAO). At the time of writing, the Alcidion share price is trading 4.17% higher at 12.5 cents.

    Strong start to the year

    Alcidion has posted very strong numbers despite the ongoing impacts of the global pandemic. The healthcare small cap announced $4.8 million in new contracted revenue. This number is up 30% on the previous quarter’s results and up a huge 92% from the prior corresponding period (pcp). Despite this sizeable increase in revenue, the Alcidion share price has slumped 40% over the past year.

    As a result of the company’s surging revenue during the quarter, total contracted revenue to be realised in FY2021 has also increased. Alcidion reported this number stands at $14.7 million. Furthermore, the company reported strong cash receipts from customers of $6.4 million, a 34% increase on a year ago.

    Despite the rise in income, Alcidion still reported net cash outflows of $1.2 million. However, it should be noted that this number reflects ongoing investment in growing the business and was in line with the company’s expectations.

    Alcidion had cash reserves of $14.7 million at the end of the first quarter. 

    Comments

    Alcidion Managing Director, Kate Quirk, was pleased with the results, stating:

    I am pleased with the strong start we have made to the new financial year. It has been an important sales quarter in Australia, where we signed initial contracts with significant potential for future expansion.

    We continue to scale up our sales, product implementation and marketing capabilities to accelerate growth in all markets, as healthcare undergoes unprecedented digital transformation. Investment in these areas will remain our focus throughout the financial year to support further growth and firmly establish Alcidion as a leading provider of digital healthcare solutions in this rapidly growing market.

    About the Alcidion share price

    Alcidion is a Melbourne-based company that is focused on developing a range of software products for use in the healthcare sector. Some of the company’s most prominent brands are Miya and Patientrack. These platforms enable medical professionals to better manage their time and patients.

    As at October 2020, the company’s platforms are utilised by more than 65,000 users across over 300 hospitals in Australia, New Zealand and the United Kingdom.

    Despite strong revenue growth over the last couple of years, the Alcidion share price has been on a downward trend since reaching all time highs of 30 cents in September last year. Shareholders will be hoping the company’s ongoing revenue growth will help drive a turnaround in the Alcidion share price.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Daniel Ewing has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Alcidion Group Ltd. The Motley Fool Australia has recommended Alcidion Group Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Alcidion (ASX:ALC) share price storms higher on update appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3dXEwj1

  • Why the Clinuvel (ASX:CUV) share price is climbing higher today

    thumbs up

    The Clinuvel Pharmaceuticals Limited (ASX: CUV) share price has returned from its trading halt and is pushing higher on Tuesday afternoon.

    At the time of writing, the biopharmaceutical company’s shares are up almost 1% to $22.11.

    Why is the Clinuvel share price pushing higher?

    Investors have been buying the company’s shares today following the release of an update on its Scenesse product.

    Scenesse is the first treatment to provide erythropoietic protoporphyria patients (EPP) with protection from the wavelengths of light that cause phototoxicity. It reduces the number and severity of reactions and increases the amount of time that sufferers can be exposed to light.

    Management notes that since the drug has been made available in Europe in 2016 and the United States in 2020, patients report that they have been given a freedom they never had imagined.

    The good news for Australians with EPP, is that Clinuvel has just received approval for Scenesse to be prescribed in Australia. It will soon be listed on the Australian Therapeutic Goods Register following approval from the Therapeutic Goods Administration (TGA).

    The release explains that Scenesse will be registered for the indication prevention of phototoxicity in adult patients with EPP. It will be available as a prescription medication, to be administered by trained and accredited healthcare professionals.

    In light of the latter, the company will implement a comprehensive training and accreditation program and ensure that healthcare professionals are provided with information in line with the Australian approval.

    Clinuvel’s Chief Scientific Officer, Dr Dennis Wright, commented: “Our team is delighted that an Australian innovation is returning home as an approved drug and will be made available for Australian EPP patients.”

    “I recognise the work of patients, physicians, TGA staff and our team to facilitate today’s outcome, which is the result of many years of engagement and dialogue. Our objective has been clear: to find ways to enable all EPP patients worldwide to access the first ever treatment for this disorder which is largely misunderstood but which causes patients a lifelong imprisonment, away from a normal outdoor life,” he concluded.

    Man who said buy Kogan shares at $3.63 says buy these 3 ASX stocks now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Why the Clinuvel (ASX:CUV) share price is climbing higher today appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3mrgJeo